Preclinical characterization of MDL 27,192 as a potential broad spectrum anticonvulsant agent with neuroprotective properties

Epilepsy Research
J H KehneH S White

Abstract

The compound 5-(4-chlorophenyl)-2,4-dihydro-4-ethyl-3H-1,2,4-triazol-3-one (MDL 27,192) was evaluated in a variety of rodent models to assess its anticonvulsant profile and its potential neuroprotective activity. MDL 27,192 demonstrated anticonvulsant activity in a wide range of epilepsy models that are genetically-based (audiogenic seizures in the seizure susceptible DBA/2J or Frings mouse; spike wave seizures in genetic absence epilepsy rats of Strasbourg (GAERS), electrically-based (MES seizures in mice and rats, corneally-kindled seizures in rats) and chemically-based (bicuculline, PTZ, picrotoxin, 3-mercaptopropionic acid, quinolinic acid and strychnine). When compared to valproate, orally administered MDL 27,192 was 17-48-fold more potent as an anticonvulsant and showed a safety index one to three-fold greater. Following a timed intravenous administration of PTZ to mice, MDL 27,192, but not phenytoin or carbamazepine, consistently increased the latencies to first twitch and clonus. MDL 27,192 was active in a genetic model of absence epilepsy, the GAERS rat model. These data indicate that MDL 27,192 likely exerts its anticonvulsant action by affecting seizure spread and by raising seizure threshold. MDL 27,192 did not disp...Continue Reading

References

Aug 1, 1992·British Journal of Pharmacology·J H KehneA M Ogden
Feb 28, 1991·The New England Journal of Medicine·J M Astrachan
Oct 1, 1990·Journal of Medicinal Chemistry·J M KaneF P Miller
Aug 1, 1988·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·S BrintW Pulsinelli
May 1, 1993·Epilepsy Research·E A SwinyardE G Drust
Mar 1, 1957·British Journal of Pharmacology and Chemotherapy·T J HALEY, W G MCCORMICK

❮ Previous
Next ❯

Citations

Mar 7, 2000·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·K E StephanR Kötter
Mar 7, 2000·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R Kötter, F T Sommer
Dec 12, 2001·CNS Drugs·A Nicolson, J P Leach
Jan 8, 2015·Seizure : the Journal of the British Epilepsy Association·Eunice S M Yuen, Iñaki F Trocóniz
Mar 19, 2008·Neuropharmacology·Tae-Cheon KangOh-Shin Kwon
May 8, 2009·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·M ShaliniJ P Stables
Jan 28, 2006·Bioorganic & Medicinal Chemistry Letters·Saeed EmamiAbbas Shafiee
Oct 22, 2009·The Annals of Pharmacotherapy·Jacklyn A Harris, Julie A Murphy
Feb 1, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·Ming-Xia Song, Xian-Qing Deng
Oct 3, 2006·Current Opinion in Anaesthesiology·P J Andrews

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Absence Epilepsy

Absence epilepsy is a common seizure disorder in children which can produce chronic psychosocial sequelae. Discover the latest research on absence epilepsies here.